Skip to content
naulon

Not checkedNot checked for notices yet.

Metformin-associated lactic acidosis in a peritoneal dialysis patient

Najlaa Almaleki, Mohammad Ashraf, Majdi M Hussein and 1 more

Saudi Journal of Kidney Diseases and Transplantation · 2015

doi:10.4103/1319-2442.152498 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Metformin is one of the commonly used drugs in type-2 diabetes mellitus. It reduces glucose levels by increasing insulin sensitivity, reducing hepatic glucose release and increasing muscle uptake. One of the serious complications associated with metformin use is lactic acidosis, and it is associated with high morbidity and mortality. This is more likely to happen in patients with renal failure due to reduced clearance. International guidelines recommend discontinuing metformin in advanced renal failure. We report a case of metformin-associated lactic acidosis in a patient with end-stage renal disease on peritoneal dialysis. The patient presented with severe lactic acidosis, which was successfully treated with hemodialysis.

Abstract licence: CC BY-NC-SA

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.